Anaptys Scraps Development of ANB032, Stock Plunges 33%

Seeking Alpha50minutes ago

TD Cowen Maintains GlaxoSmithKline(GSK.US) With Hold Rating, Maintains Target Price $45

Futu NewsDec 11 23:32 · Ratings

Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TipRanksDec 11 20:35 · Ratings

GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex

BenzingaDec 11 02:14

India Drug Delivery Devices Market 2024, With Profiles of Pfizer, Novartis, GlaxoSmithKline, India Medtronic, Cardinal Health, B. Braun Medical, Sun Pharmaceutical, 3M, Cipla & Bayer Zydus Pharma

Yahoo FinanceDec 10 20:25

GSK, Relation Therapeutics Partner to Advance Osteoarthritis, Fibrotic Disease Treatments

WSJDec 10 16:24